The management of myelofibrosis: A British Society for Haematology Guideline.

MLA

McLornan, Donal P., et al. “The Management of Myelofibrosis: A British Society for Haematology Guideline.” British Journal of Haematology, vol. 204, no. 1, Jan. 2024, pp. 136–50. EBSCOhost, https://doi.org/10.1111/bjh.19186.

APA

McLornan, D. P., Psaila, B., Ewing, J., Innes, A., Arami, S., Brady, J., Butt, N. M., Cargo, C., Cross, N. C. P., Francis, S., Frewin, R., Garg, M., Godfrey, A. L., Green, A., Khan, A., Knapper, S., Lambert, J., McGregor, A., McMullin, M. F., & Nangalia, J. (2024). The management of myelofibrosis: A British Society for Haematology Guideline. British Journal of Haematology, 204(1), 136–150. https://doi.org/10.1111/bjh.19186

Chicago

McLornan, Donal P., Bethan Psaila, Joanne Ewing, Andrew Innes, Siamak Arami, Jessica Brady, Nauman M. Butt, et al. 2024. “The Management of Myelofibrosis: A British Society for Haematology Guideline.” British Journal of Haematology 204 (1): 136–50. doi:10.1111/bjh.19186.